abstract |
Provided herein are aptamers that can inhibit the activity of von Willebrand Factor (VWF). Pharmaceutical compositions containing these aptamers are also provided. A method for preventing clot formation in a subject animal by administering the aptamer is provided, and a method for treating a clot by administering a VWF target drug is also provided. |